1
|
Elsinga J, van Meijeren D, Reubsaet F. Surveillance of diphtheria in the Netherlands between 2000-2021: cutaneous diphtheria supersedes the respiratory form. BMC Infect Dis 2023; 23:420. [PMID: 37344769 PMCID: PMC10283224 DOI: 10.1186/s12879-023-08388-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2023] [Accepted: 06/08/2023] [Indexed: 06/23/2023] Open
Abstract
BACKGROUND Diphtheria is a severe respiratory or cutaneous infectious disease, caused by exotoxin producing Corynebacterium diphtheriae, C. ulcerans and C. pseudotuberculosis. Diphtheria is once again prevalent due to breakdown of immunisation programmes, social disruption and unrest. AIM This study describes the notified diphtheria cases in the Netherlands between 2000-2021 and isolates that were sent to the National Institute for Public Health and the Environment (RIVM). METHODS File investigation was performed including all notified cases and isolates of C. diphtheriae, C. ulcerans and C. pseudotuberculosis that were tested for toxin production using a toxin-PCR and Elek test. An exploratory review was performed to understand transmission in populations with a high vaccination uptake. RESULTS Eighteen diphtheria notifications were made with confirmed toxigenic C. diphtheriae (n = 9) or ulcerans (n = 9) between 2000 and 2021. Seventeen (94.4%) presented with a cutaneous infection. All cases with a suspected source abroad (n = 8) concerned infection with C. diphtheriae. In contrast, 9/10 cases infected in the Netherlands were caused by C. ulcerans, a zoonosis. Secondary transmission was not reported. Isolates of C. ulcerans sent to the RIVM produced more often the diphtheria exotoxin (11/31; 35%) than C. diphtheriae (7/89; 7.9%). CONCLUSION Both human-to-human transmission of C. diphtheriae and animal-to-human transmission of C. ulcerans rarely occurs in the Netherlands. Cases mainly present with a cutaneous infection. Travel-related cases remain a risk for transmission to populations with low vaccination coverage, highlighting the importance of immunization and diphtheria control measures.
Collapse
Affiliation(s)
- Jelte Elsinga
- Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Antonie Van Leeuwenhoeklaan 9, 3721 MA, Bilthoven, The Netherlands.
- Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
| | - Dimphey van Meijeren
- Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Antonie Van Leeuwenhoeklaan 9, 3721 MA, Bilthoven, The Netherlands
| | - Frans Reubsaet
- Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Antonie Van Leeuwenhoeklaan 9, 3721 MA, Bilthoven, The Netherlands
| |
Collapse
|
2
|
Microbiological and Clinical Aspects of Diphtheria-Confirmed Cases from Capital City of Indonesia, Jakarta, and Surrounding Areas in 2017. Jundishapur J Microbiol 2021. [DOI: 10.5812/jjm.118751] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
Abstract
Background: The World Health Organization reported Indonesia as one of the countries with the most prevalent cases of diphtheria worldwide. The microbiological aspects of diphtheria-inducing bacteria are of great significance in tracing disease transmission and case management. However, clinical aspects are critical for updating clinical features and case management in the field, which may sometimes differ from theoretical foundations. Objectives: This study aimed to identify the microbiological and clinical aspects, including molecular typing and case fatality rates, in diphtheria-confirmed cases from the capital city of Indonesia, Jakarta, and surrounding areas in 2017. Methods: The microbiological aspect of 40 diphtheria-confirmed cases were obtained by re-identify diphtheria-inducing bacteria isolated from the samples, while the clinical aspects of the cases were obtained from the medical records and epidemiological data. The chi-square test was used to examine the correlation between fatal cases and myocarditis and diphtheria antitoxin administration delay. In this study, P ≤ 0.05 was set as the significance level. Results: All 40 diphtheria confirmed cases were induced by toxigenic Corynebacterium diphtheriae with two biotypes, namely intermedius (60.0%) and mitis (40.0%). There are six sequence types of bacteria with two main sequence types, ie, ST534 (46.4%) and ST377 (35.7%). The proportions of cases that had a fever and sore throat were 72.5% and 77.5%, respectively; however, the prevalence rates of the cases with pseudomembrane and bull neck were 100% and 47%, respectively. Most cases were administered a combination of penicillin or erythromycin with other antibiotics (40%), and 22.5% of the cases only received penicillin. Myocarditis was noticed in three fatal cases, and their relationship was statistically significant (P = 0.000). All five fatal cases (12.5% of cases) received diphtheria antitoxin (DAT) lately or had not received it yet. Conclusions: Toxigenic C. diphtheriae with two biotypes (namely mitis and intermedius) and two main sequence types (ie, ST534 and ST377) was the causative agent of diphtheria-confirmed cases from Jakarta and surrounding areas in 2017. It was also concluded that those fatal cases were correlated with myocarditis complications.
Collapse
|
3
|
Sunarno, Khariri, Muna F, Sariadji K, Rukminiati Y, Febriyana D, Febrianti T, Saraswati RD, Susanti I, Puspandari N, Karuniawati A, Malik A, Soebandrio A. New approach for the identification of potentially toxigenic Corynebacterium sp. using a multiplex PCR assay. J Microbiol Methods 2021; 184:106198. [PMID: 33713727 DOI: 10.1016/j.mimet.2021.106198] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2021] [Revised: 03/08/2021] [Accepted: 03/08/2021] [Indexed: 10/22/2022]
Abstract
In diphtheria laboratory examinations, the PCR test can be applied to isolates and clinical specimens. This study aimed to develop a PCR assay to identify the species and toxigenicity of diphtheria-causing bacteria, including the prediction of some NTTB types. Seven reference isolates, four synthetic DNA samples, 36 stored isolates, and 487 clinical samples used for PCR optimization. The PCR results was confirmed by DNA sequence analysis. The results of the PCR examination of the 7 reference isolates and 36 stored isolates were similar to the results obtained using conventional methods as gold standard, both for diphtheria-causing and non-diphtheria-causing bacteria. The validation of the PCR results using DNA sequence analysis showed that there was no mispriming or misamplification. The multiplex PCR assay developed in this study could correctly identify the species and toxigenicity of diphtheria-causing bacteria, including the prediction of some NTTB types not yet covered by established PCR methods.
Collapse
Affiliation(s)
- Sunarno
- Centre for Research and Development of Biomedical and Basic Health Technology, National Institute of Health Research and Development, Ministry of Health, Jakarta, Indonesia.
| | - Khariri
- Centre for Research and Development of Biomedical and Basic Health Technology, National Institute of Health Research and Development, Ministry of Health, Jakarta, Indonesia
| | - Fauzul Muna
- Centre for Research and Development of Biomedical and Basic Health Technology, National Institute of Health Research and Development, Ministry of Health, Jakarta, Indonesia
| | - Kambang Sariadji
- Centre for Research and Development of Biomedical and Basic Health Technology, National Institute of Health Research and Development, Ministry of Health, Jakarta, Indonesia
| | - Yuni Rukminiati
- Centre for Research and Development of Biomedical and Basic Health Technology, National Institute of Health Research and Development, Ministry of Health, Jakarta, Indonesia
| | - Dwi Febriyana
- Centre for Research and Development of Biomedical and Basic Health Technology, National Institute of Health Research and Development, Ministry of Health, Jakarta, Indonesia
| | - Tati Febrianti
- Centre for Research and Development of Biomedical and Basic Health Technology, National Institute of Health Research and Development, Ministry of Health, Jakarta, Indonesia
| | - Ratih Dian Saraswati
- Centre for Research and Development of Biomedical and Basic Health Technology, National Institute of Health Research and Development, Ministry of Health, Jakarta, Indonesia
| | - Ida Susanti
- Centre for Research and Development of Biomedical and Basic Health Technology, National Institute of Health Research and Development, Ministry of Health, Jakarta, Indonesia
| | - Nelly Puspandari
- Centre for Research and Development of Biomedical and Basic Health Technology, National Institute of Health Research and Development, Ministry of Health, Jakarta, Indonesia
| | | | - Amarila Malik
- Division of Microbiology and Biotechnology Pharmacy, Faculty of Pharmacy, Universitas Indonesia, Depok, Indonesia
| | - Amin Soebandrio
- Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Eijkman Institute for Molecular Biology, Jakarta, Indonesia
| |
Collapse
|
4
|
Cholewa S, Karachiwalla F, Wilson SE, Nadarajah J, Kus JV. Diphtérie respiratoire mortelle chez une personne en visite au Canada. CMAJ 2021; 193:E355-E358. [PMID: 33685959 PMCID: PMC8034323 DOI: 10.1503/cmaj.200707-f] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
Affiliation(s)
- Scott Cholewa
- Direction générale de la santé publique (Cholewa, Karachiwalla), municipalité régionale de York, Newmarket, Ont.; École de santé publique Dalla Lana (Karachiwalla, Wilson) et Faculté de médecine (Nadarajah) et Département de médecine de laboratoire et de pathologie (Kus), Université de Toronto; Santé publique Ontario (Wilson, Kus), Toronto, Ont.; Département de médecine familiale, École de médecine (Karachiwalla), Université Queen's, Kingston, Ont.; Institut de recherche en services de santé (Wilson), Toronto, Ont.
| | - Fareen Karachiwalla
- Direction générale de la santé publique (Cholewa, Karachiwalla), municipalité régionale de York, Newmarket, Ont.; École de santé publique Dalla Lana (Karachiwalla, Wilson) et Faculté de médecine (Nadarajah) et Département de médecine de laboratoire et de pathologie (Kus), Université de Toronto; Santé publique Ontario (Wilson, Kus), Toronto, Ont.; Département de médecine familiale, École de médecine (Karachiwalla), Université Queen's, Kingston, Ont.; Institut de recherche en services de santé (Wilson), Toronto, Ont
| | - Sarah E Wilson
- Direction générale de la santé publique (Cholewa, Karachiwalla), municipalité régionale de York, Newmarket, Ont.; École de santé publique Dalla Lana (Karachiwalla, Wilson) et Faculté de médecine (Nadarajah) et Département de médecine de laboratoire et de pathologie (Kus), Université de Toronto; Santé publique Ontario (Wilson, Kus), Toronto, Ont.; Département de médecine familiale, École de médecine (Karachiwalla), Université Queen's, Kingston, Ont.; Institut de recherche en services de santé (Wilson), Toronto, Ont
| | - Jeya Nadarajah
- Direction générale de la santé publique (Cholewa, Karachiwalla), municipalité régionale de York, Newmarket, Ont.; École de santé publique Dalla Lana (Karachiwalla, Wilson) et Faculté de médecine (Nadarajah) et Département de médecine de laboratoire et de pathologie (Kus), Université de Toronto; Santé publique Ontario (Wilson, Kus), Toronto, Ont.; Département de médecine familiale, École de médecine (Karachiwalla), Université Queen's, Kingston, Ont.; Institut de recherche en services de santé (Wilson), Toronto, Ont
| | - Julianne V Kus
- Direction générale de la santé publique (Cholewa, Karachiwalla), municipalité régionale de York, Newmarket, Ont.; École de santé publique Dalla Lana (Karachiwalla, Wilson) et Faculté de médecine (Nadarajah) et Département de médecine de laboratoire et de pathologie (Kus), Université de Toronto; Santé publique Ontario (Wilson, Kus), Toronto, Ont.; Département de médecine familiale, École de médecine (Karachiwalla), Université Queen's, Kingston, Ont.; Institut de recherche en services de santé (Wilson), Toronto, Ont
| |
Collapse
|
5
|
Molecular and Epidemiological Characterization of Toxigenic and Nontoxigenic Corynebacterium diphtheriae, Corynebacterium belfantii, Corynebacterium rouxii, and Corynebacterium ulcerans Isolates Identified in Spain from 2014 to 2019. J Clin Microbiol 2021; 59:JCM.02410-20. [PMID: 33298610 DOI: 10.1128/jcm.02410-20] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2020] [Accepted: 11/21/2020] [Indexed: 11/20/2022] Open
Abstract
This study examines the microbiological and epidemiological characteristics of toxigenic and nontoxigenic Corynebacterium isolates submitted to the national reference laboratory in Spain, between 2014 and 2019, in order to describe the current situation and improve our knowledge regarding these emerging pathogens. Epidemiological information was extracted from the Spanish Surveillance System. Microbiological and molecular characterization was carried out using phenotypic methods, multilocus sequence typing (MLST), whole-genome sequencing (WGS), and core genome MLST (cgMLST). Thirty-nine isolates were analyzed. Twenty-one isolates were identified as Corynebacterium diphtheriae (6 toxigenic), 14 as C. belfantii, 4 as C. ulcerans (3 toxigenic), and 1 as C. rouxii One C. diphtheriae isolate was identified as nontoxigenic tox gene bearing (NTTB). Ages of patients ranged from 1 to 89 years, with 10% (3/30) of nontoxigenic and 22% (2/9) of toxigenic isolates collected from children less than 15 years. Twenty-five of the patients were males (17/30 in nontoxigenic; 8/9 in toxigenic). MLST identified 28 sequence types (STs), of which 7 were described for the first time in Spain. WGS analysis showed that 10 isolates, including 3 toxigenic isolates, harbored a variety of antibiotic resistance genes in addition to the high prevalence of penicillin resistance phenotypically demonstrated. Phylogenetic analysis revealed one cluster of isolates from family members. Risk information was available for toxigenic isolates (9/39); 3 patients reported recent travels to countries of endemicity and 3 had contact with cats/dogs. One unvaccinated child with respiratory diphtheria had a fatal outcome. Including nontoxigenic Corynebacterium infections in disease surveillance and using WGS could further improve current surveillance.
Collapse
|
6
|
Cholewa S, Karachiwalla F, Wilson SE, Nadarajah J, Kus JV. Fatal respiratory diphtheria in a visitor to Canada. CMAJ 2021; 193:E19-E22. [PMID: 33397635 PMCID: PMC7774478 DOI: 10.1503/cmaj.200707] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Affiliation(s)
- Scott Cholewa
- Public Health Branch (Cholewa, Karachiwalla), Regional Municipality of York, Newmarket, Ont.; Dalla Lana School of Public Health (Karachiwalla, Wilson), and Faculty of Medicine (Nadarajah), and Department of Laboratory Medicine and Pathobiology (Kus), University of Toronto; Public Health Ontario (Wilson, Kus), Toronto, Ont.; Department of Family Medicine, School of Medicine (Karachiwalla), Queen's University, Kingston, Ont.; Institute for Clinical Evaluative Studies, (Wilson), Toronto, Ont.
| | - Fareen Karachiwalla
- Public Health Branch (Cholewa, Karachiwalla), Regional Municipality of York, Newmarket, Ont.; Dalla Lana School of Public Health (Karachiwalla, Wilson), and Faculty of Medicine (Nadarajah), and Department of Laboratory Medicine and Pathobiology (Kus), University of Toronto; Public Health Ontario (Wilson, Kus), Toronto, Ont.; Department of Family Medicine, School of Medicine (Karachiwalla), Queen's University, Kingston, Ont.; Institute for Clinical Evaluative Studies, (Wilson), Toronto, Ont
| | - Sarah E Wilson
- Public Health Branch (Cholewa, Karachiwalla), Regional Municipality of York, Newmarket, Ont.; Dalla Lana School of Public Health (Karachiwalla, Wilson), and Faculty of Medicine (Nadarajah), and Department of Laboratory Medicine and Pathobiology (Kus), University of Toronto; Public Health Ontario (Wilson, Kus), Toronto, Ont.; Department of Family Medicine, School of Medicine (Karachiwalla), Queen's University, Kingston, Ont.; Institute for Clinical Evaluative Studies, (Wilson), Toronto, Ont
| | - Jeya Nadarajah
- Public Health Branch (Cholewa, Karachiwalla), Regional Municipality of York, Newmarket, Ont.; Dalla Lana School of Public Health (Karachiwalla, Wilson), and Faculty of Medicine (Nadarajah), and Department of Laboratory Medicine and Pathobiology (Kus), University of Toronto; Public Health Ontario (Wilson, Kus), Toronto, Ont.; Department of Family Medicine, School of Medicine (Karachiwalla), Queen's University, Kingston, Ont.; Institute for Clinical Evaluative Studies, (Wilson), Toronto, Ont
| | - Julianne V Kus
- Public Health Branch (Cholewa, Karachiwalla), Regional Municipality of York, Newmarket, Ont.; Dalla Lana School of Public Health (Karachiwalla, Wilson), and Faculty of Medicine (Nadarajah), and Department of Laboratory Medicine and Pathobiology (Kus), University of Toronto; Public Health Ontario (Wilson, Kus), Toronto, Ont.; Department of Family Medicine, School of Medicine (Karachiwalla), Queen's University, Kingston, Ont.; Institute for Clinical Evaluative Studies, (Wilson), Toronto, Ont
| |
Collapse
|
7
|
Georgakopoulou T, Tryfinopoulou K, Doudoulakakis A, Nikolaou F, Magaziotou I, Flountzi A, Fry NK, Litt DJ, Damala M, Spiliopoulou I, Liatsi-Douvitsa E, Lebessi E, Panayiotakopoulos G, Tsolia M, Saroglou G, Theodoridou M, Tsiodras S, Efstratiou A. A patient with respiratory toxigenic diphtheria in Greece after more than 30 years. Epidemiol Infect 2020; 148:e274. [PMID: 33109284 PMCID: PMC7770372 DOI: 10.1017/s0950268820002605] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2020] [Revised: 08/28/2020] [Accepted: 10/02/2020] [Indexed: 11/06/2022] Open
Abstract
The introduction of treatment and systematic vaccination has significantly reduced diphtheria mortality; however, toxigenic strains continue to circulate worldwide. The emergence of an indigenous diphtheria case with fatal outcome in Greece, after 30 years, raised challenges for laboratory confirmation, clinical and public health management. Toxigenic Corynebacterium diphtheriae was isolated from an incompletely vaccinated 8-year-old boy with underlying conditions. The child passed away due to respiratory distress syndrome, before the administration of diphtheria antitoxin (DAT). All close contacts in family, school and hospital settings were investigated. Pharyngeal swabs were obtained to determine asymptomatic carriage. Chemoprophylaxis was given for 7 days to all close contacts and a booster dose to those incompletely vaccinated. Testing revealed a classmate, belonging to a subpopulation group (Roma), and incompletely vaccinated, as an asymptomatic carrier with an indistinguishable toxigenic strain (same novel multilocus sequence type, designated ST698). This case highlights the role of asymptomatic carriage, as the entry of toxigenic strains into susceptible populations can put individuals and their environment at risk. Maintenance of high-level epidemiological and microbiological surveillance, implementation of systematic vaccination in children and adults with primary and booster doses, availability of a DAT stockpile, and allowing timely administration are the cornerstone to prevent similar incidents in the future.
Collapse
Affiliation(s)
- T. Georgakopoulou
- Department for Vaccine Preventable Diseases & Congenital Diseases, National Public Health Organization (NPHO), Athens, Greece
| | - K. Tryfinopoulou
- Central Public Health Laboratory, National Public Health Organization (NPHO), Athens, Greece
| | - A. Doudoulakakis
- Department of Microbiology, P. & A. Kyriakou Children's Hospital, Athens, Greece
| | - F. Nikolaou
- Paediatric Intensive Care Unit, P. & A. Kyriakou Children's Hospital, Athens, Greece
| | - I. Magaziotou
- Department for Vaccine Preventable Diseases & Congenital Diseases, National Public Health Organization (NPHO), Athens, Greece
| | - A. Flountzi
- Central Public Health Laboratory, National Public Health Organization (NPHO), Athens, Greece
| | - N. K. Fry
- WHO Global Collaborating Centre for Reference and Research on Diphtheria and Streptococcal Infections, Reference Microbiology Division, National Infection Service, Public Health England, London, UK
- Immunisation and Countermeasures Division, Public Health England – National Infection Service, London, UK
| | - D. J Litt
- WHO Global Collaborating Centre for Reference and Research on Diphtheria and Streptococcal Infections, Reference Microbiology Division, National Infection Service, Public Health England, London, UK
| | - M. Damala
- Department of Microbiology, P. & A. Kyriakou Children's Hospital, Athens, Greece
| | - I. Spiliopoulou
- Central Public Health Laboratory, National Public Health Organization (NPHO), Athens, Greece
| | - E. Liatsi-Douvitsa
- Research Unit of Advanced Composite Nano Materials & Nanotechnology, School of Chemical Engineering, National Technical University of Athens, Athens, Greece
| | - E. Lebessi
- Department of Microbiology, P. & A. Kyriakou Children's Hospital, Athens, Greece
| | | | - M. Tsolia
- 2nd Department of Paediatrics, National and Kapodistrian University of Athens School of Health Sciences, Greece
| | - G. Saroglou
- Internal Medicine Department, Metropolitan Hospital, Athens, Greece
| | - M. Theodoridou
- First Department of Pediatrics, Aghia Sophia Children's Hospital, University of Athens, Greece
| | - S. Tsiodras
- National Public Health Organization (NPHO), Athens, Greece
- 4th Department of Internal Medicine, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, Greece
| | - A. Efstratiou
- WHO Global Collaborating Centre for Reference and Research on Diphtheria and Streptococcal Infections, Reference Microbiology Division, National Infection Service, Public Health England, London, UK
| |
Collapse
|
8
|
Alberto C, Osdoit S, Villani AP, Bellec L, Belmonte O, Schrenzel J, Bagny K, Badell E, Brisse S, Toubiana J. Cutaneous ulcers revealing diphtheria: A re-emerging disease imported from Indian Ocean countries? Ann Dermatol Venereol 2020; 148:34-39. [PMID: 32631628 DOI: 10.1016/j.annder.2020.04.024] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2019] [Revised: 12/20/2019] [Accepted: 04/03/2020] [Indexed: 10/23/2022]
Abstract
INTRODUCTION Diphtheria due to Corynebacteriumdiphtheriae (C. diphtheriae) has become rare in developed countries. In France only 10 cases of toxigenic diphtheria have been reported since 1989, in all cases causing pharyngitis and all emanating from endemic countries with exception of one contact case. We report herein 13 cases with cutaneous diphtheria, in 5 of which diphtheria toxin was produced, and all imported into France between 2015 and 2018. OBSERVATIONS Thirteen patients aged 4 to 77 years presented painful and rapidly progressive round ulcerations of the legs, that were superficial and in some cases purulent, with an erythematous-purple border covered with greyish membrane. Bacteriological sampling of ulcers revealed the presence of C. diphtheriae. Only 6 patients had been properly immunized over the preceding 5 years. DISCUSSION These cases underline the resurgence of cutaneous diphtheria and the circulation of toxigenic strains in France following importation from Indian Ocean countries. This may constitute an important reservoir for ongoing transmission of the disease. Re-emergence of this pathogen stems from the current migratory flow and decreased adult booster coverage. CONCLUSION Cutaneous diphtheria should be considered in cases of rapidly developing painful skin ulcers with greyish membrane, especially among patients returning from endemic areas, regardless of their vaccination status. The clinician should order specific screening for C. diphtheriae from the bacteriologist, since with routine swabbing Corynebacteriaceae may be reported simply as normal skin flora. Vaccination protects against toxigenic manifestations but not against actual bacterial infection. Early recognition and treatment of cutaneous diphtheria and up-to-date vaccination are mandatory to avoid further transmission and spread of both cutaneous and pharyngeal diphtheria.
Collapse
Affiliation(s)
- C Alberto
- Department of dermatology, Geneva university hospital, Geneva, Switzerland.
| | - S Osdoit
- Department of dermatology and internal medicine, Felix Guyon university hospital, Saint-Denis, Reunion
| | - A-P Villani
- Department of dermatology, Claude Bernard Lyon I university, Edouard Herriot hospital, Lyon, France
| | - L Bellec
- Department of infectious diseases, Felix Guyon university hospital, Saint-Denis, Reunion
| | - O Belmonte
- Laboratory of microbiology, Felix Guyon university hospital, Saint-Denis, Reunion
| | - J Schrenzel
- Laboratory of bacteriology, Geneva university hospitals, Geneva, Switzerland
| | - K Bagny
- Department of dermatology and internal medicine, Felix Guyon university hospital, Saint-Denis, Reunion
| | - E Badell
- Institut Pasteur, Biodiversity and Epidemiology of Bacterial Pathogens, 75000 Paris, France; Institut Pasteur, National Reference Center for the Corynebacteria of the diphtheriae complex, 75000 Paris, France
| | - S Brisse
- Institut Pasteur, Biodiversity and Epidemiology of Bacterial Pathogens, 75000 Paris, France; Institut Pasteur, National Reference Center for the Corynebacteria of the diphtheriae complex, 75000 Paris, France
| | - J Toubiana
- Institut Pasteur, Biodiversity and Epidemiology of Bacterial Pathogens, 75000 Paris, France; Institut Pasteur, National Reference Center for the Corynebacteria of the diphtheriae complex, 75000 Paris, France; Université de Paris, Department of General Paediatrics and Paediatric Infectious Diseases, 75000 Paris, France
| |
Collapse
|
9
|
Evelyn C, Vettiyil GI, Jennifer S. L, Rose W. Umbilical Diphtheria: Resurgence of a Forgotten Entity. Indian Pediatr 2020. [DOI: 10.1007/s13312-020-1765-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
10
|
Barrado L, Beristain X, Martín-Salas C, Ezpeleta-Baquedano C. Corynebacterium diphtheriae biotipo belfanti no toxigénico en una paciente diabética con infección del tracto respiratorio superior. Enferm Infecc Microbiol Clin 2019; 37:680-681. [DOI: 10.1016/j.eimc.2018.10.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2018] [Revised: 10/03/2018] [Accepted: 10/08/2018] [Indexed: 11/28/2022]
|
11
|
Martini H, Soetens O, Litt D, Fry NK, Detemmerman L, Wybo I, Desombere I, Efstratiou A, Piérard D. Diphtheria in Belgium: 2010-2017. J Med Microbiol 2019; 68:1517-1525. [PMID: 31418673 DOI: 10.1099/jmm.0.001039] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023] Open
Abstract
In Western Europe, the incidence of both respiratory and cutaneous diphtheria, caused by toxin-producing Corynebacterium diphtheriae, Corynebacterium ulcerans or Corynebacterium pseudotuberculosis, has been low over the past few decades thanks to the use of an effective vaccine and a high level of vaccination coverage. However, the disease has still not been eradicated and continues to occur in all of Europe. In order to prevent sequelae or a fatal outcome, diphtheria antitoxin (DAT) should be administered to suspected diphtheria patients as soon as possible, but economic factors and issues concerning regulations have led to poor availability of DAT in many countries. The European Centre for Disease Prevention and Control and World Health Organization have called for European Union-wide solutions to this DAT-shortage. In order to illustrate the importance of these efforts and underline the need for continued diphtheria surveillance, we present data on all registered cases of toxigenic and non-toxigenic C. diphtheriae, C. ulcerans and C. pseudotuberculosis in Belgium during the past decade, up to and including 2017.
Collapse
Affiliation(s)
- Helena Martini
- Department of Microbiology, National Reference Centre for toxigenic corynebacteria, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, 1090 Brussels, Belgium
| | - Oriane Soetens
- Department of Microbiology, National Reference Centre for toxigenic corynebacteria, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, 1090 Brussels, Belgium
| | - David Litt
- Respiratory and Vaccine Preventable Bacteria Reference Unit, Public Health England - National Infection Service, London, UK
| | - Norman K Fry
- Immunisation and Countermeasures Division, Public Health England - National Infection Service, London, UK.,Respiratory and Vaccine Preventable Bacteria Reference Unit, Public Health England - National Infection Service, London, UK
| | - Liselot Detemmerman
- Present address: LaCAR MDx Technologies, Liège, Belgium.,Department of Microbiology, National Reference Centre for toxigenic corynebacteria, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, 1090 Brussels, Belgium
| | - Ingrid Wybo
- Department of Microbiology, National Reference Centre for toxigenic corynebacteria, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, 1090 Brussels, Belgium
| | - Isabelle Desombere
- Present address: LaCAR MDx Technologies, Liège, Belgium.,SD Infectious Diseases in Humans, Service Immune Response, National Reference Centre for toxigenic corynebacteria, Sciensano (Public Health Belgium), Brussels, Belgium
| | - Androulla Efstratiou
- WHO Global Collaborating Centre for Reference and Research on Diphtheria and Streptococcal Infections, Public Health England - National Infection Service, London, UK
| | - Denis Piérard
- Department of Microbiology, National Reference Centre for toxigenic corynebacteria, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, 1090 Brussels, Belgium
| |
Collapse
|
12
|
Seth-Smith HMB, Egli A. Whole Genome Sequencing for Surveillance of Diphtheria in Low Incidence Settings. Front Public Health 2019; 7:235. [PMID: 31497588 PMCID: PMC6713046 DOI: 10.3389/fpubh.2019.00235] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2019] [Accepted: 08/06/2019] [Indexed: 12/29/2022] Open
Abstract
Corynebacterium diphtheriae (C. diphtheriae) is a relatively rare pathogen in most Western countries. While toxin producing strains can cause pharyngeal diphtheria with potentially fatal outcomes, the more common presentation is wound infections. The diphtheria toxin is encoded on a prophage and can also be carried by Corynebacterium ulcerans and Corynebacterium pseudotuberculosis. Currently, across Europe, infections are mainly diagnosed in travelers and refugees from regions where diphtheria is more endemic, patients from urban areas with poor hygiene, and intravenous drug users. About half of the cases are non-toxin producing isolates. Rapid identification of the bacterial pathogen and toxin production is a critical element of patient and outbreak management. Beside the immediate clinical management of the patient, public health agencies should be informed of toxigenic C. diphtheriae diagnoses as soon as possible. The collection of case-related epidemiological data from the patient is often challenging due to language barriers and social circumstances. However, information on patient contacts, vaccine status and travel/refugee route, where appropriate, is critical, and should be documented. In addition, isolates should be characterized using high resolution typing, in order to identify transmissions and outbreaks. In recent years, whole genome sequencing (WGS) has become the gold standard of high-resolution typing methods, allowing detailed investigations of pathogen transmissions. De-centralized sequencing strategies with redundancy in sequencing capacities, followed by data exchange may be a valuable future option, especially since WGS becomes more available and portable. In this context, the sharing of sequence data, using public available platforms, is essential. A close interaction between microbiology laboratories, treating physicians, refugee centers, social workers, and public health officials is a key element in successful management of suspected outbreaks. Analyzing bacterial isolates at reference centers may further help to provide more specialized microbiological techniques and to standardize information, but this is also more time consuming during an outbreak. Centralized communication strategies between public health agencies and laboratories helps considerably in establishing and coordinating effective surveillance and infection control. We review the current literature on high-resolution typing of C. diphtheriae and share our own experience with the coordination of a Swiss-German outbreak.
Collapse
Affiliation(s)
- Helena M. B. Seth-Smith
- Division of Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland
- Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland
- SIB Swiss Institute of Bioinformatics, Basel, Switzerland
| | - Adrian Egli
- Division of Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland
- Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland
| |
Collapse
|